医院与社区药师共享药物不良事件报告以指导再配药:报告与流程结局分析
研究设计ActionADE在线报告平台并与不列颠哥伦比亚省PharmaNet整合,在四家医院开展前瞻性观察研究,分析3174份药物不良事件报告。结果显示28.5%为严重或危及生命事件,社区药师响应警示后避免再配药的比例为33.0%(66/200)。
要点
- ActionADE是首个通过中央药品数据库向社区药房传递药物不良事件的可互操作平台。
- 每10份共享至PharmaNet的药物不良事件报告中约1份促使社区药师避免再暴露于可疑药物或同类药物。
- 需进一步研究ActionADE对患者和卫生系统结局的影响。
核心结论
- ActionADE是首个通过中央药品数据库向社区药房传递药物不良事件的可互操作平台。
- 每10份报告至ActionADE并共享至PharmaNet的药物不良事件中,约有1份促使社区药师避免再配发可疑药物或同类药物。
研究设计与样本
- 研究为前瞻性观察性研究,于2020年4月1日至2022年10月31日在不列颠哥伦比亚省四家医院开展药物不良事件报告。
- 共3591份药物不良事件报告由医院临床医生发起,其中3174份纳入分析。
主要发现
- 导致永久残疾、住院、延长住院和/或死亡的严重或危及生命药物不良事件占28.5%(906/3174;95%CI 27.0-30.1%)。
- 男性较女性更常报告不依从,且发生危及生命药物不良事件的年龄较女性更年轻。
- 在592例有至少1份药物不良反应或过敏报告传递至社区药房的患者中,200例随后尝试再配发可疑药物或同类药物。
- 社区药师响应预防性警示,避免再配药的比例为33.0%(66/200;95%CI 26.5-39.5%)。
临床怎么用
- 临床药师可利用ActionADE等互操作平台将药物不良事件信息传递至社区药房,辅助再配药决策。
局限性
- 需进一步研究以了解ActionADE对患者和卫生系统结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adverse drug events (ADEs) are a leading cause of unplanned hospital visits. We designed ActionADE, an online ADE reporting platform, and integrated it with PharmaNet, British Columbia's (BC's) provincial medication dispensing system, to overcome identified barriers in ADE reporting and communicate ADEs to community pharmacies. Our objectives were to characterise ADEs reported in ActionADE, explore associations between patients' age, sex and ADE characteristics, and estimate the re-dispensation rate of culprit medications in community pharmacies. METHODS: We conducted a prospective observational study of ADE reporting in four BC hospitals between April 1, 2020 and October 31, 2022. We described the characteristics of ADEs reported into ActionADE, used logistic regression modelling to examine associations between age and sex and ADE characteristics, and calculated rates of avoided culprit drug re-dispensations using community pharmacists' responses to ActionADE alerts. RESULTS: In total, 3591 ADE reports were initiated by hospital clinicians, 3174 of which were included in this analysis. Serious or life-threatening ADEs resulting in permanent disability, hospitalisation, extended hospitalisation, and/or death accounted for 28.5% (906/3174; 95% CI 27.0-30.1%) of reports. Males were more likely to have non-adherence reported compared to females and experienced life threatening ADEs at a younger age than females. Of 592 patients who had ≥ 1 adverse drug reaction or allergy report (a subset of ADEs) transmitted to community pharmacies, 200 subsequently attempted to re-fill the culprit or a same class drug. Community pharmacists responded to preventative alerts by avoiding re-dispensation in 33.0% (66/200; 95% CI 26.5-39.5%). INTERPRETATION: ActionADE is the first interoperable system that communicates ADEs via a central medication database to community pharmacies. Every 10th ADE reported in ActionADE and shared to PharmaNet resulted in community pharmacists' avoiding one culprit or same class drug re-exposure. Further research is needed to understand ActionADE's impact on patient and health system outcomes.
引用
- Cragg A, Small SS, Lau E, et al. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes. Drug Saf. 2023. PMID: 37783974. doi:10.1007/s40264-023-01348-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。